» Articles » PMID: 34722348

Stage-Specific Class I Nucleases of Play Important Roles in Parasite Infection and Survival

Overview
Date 2021 Nov 1
PMID 34722348
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Protozoans of the genus are the causative agents of an important neglected tropical disease referred to as leishmaniasis. During their lifecycle, the parasites can colonize the alimentary tract of the sand fly vector and the parasitophorous vacuole of the mammalian host, differentiating into distinct stages. Motile promastigotes are found in the sand fly vector and are transmitted to the mammalian host during the insect blood meal. Once in the vertebrate host, the parasites differentiate into amastigotes and multiply inside macrophages. To successfully establish infection in mammalian hosts, parasites exhibit various strategies to impair the microbicidal power of the host immune system. In this context, stage-specific class I nucleases play different and important roles related to parasite growth, survival and development. Promastigotes express 3'-nucleotidase/nuclease (3'-NT/NU), an ectoenzyme that can promote parasite escape from neutrophil extracellular traps (NET)-mediated death through extracellular DNA hydrolysis and increase -macrophage interactions due to extracellular adenosine generation. Amastigotes express secreted nuclease activity during the course of human infection that may be involved in the purine salvage pathway and can mobilize extracellular nucleic acids available far from the parasite. Another nuclease expressed in amastigotes (P4/LmC1N) is located in the endoplasmic reticulum of the parasite and may be involved in mRNA stability and DNA repair. Homologs of this class I nuclease can induce protection against infection by eliciting a T helper 1-like immune response. These immunogenic properties render these nucleases good targets for the development of vaccines against leishmaniasis, mainly because amastigotes are the form responsible for the development and progression of the disease. The present review aims to present and discuss the roles played by different class I nucleases during the lifecycle, especially regarding the establishment of mammalian host infection.

Citing Articles

Evolutionary divergent clusters of transcribed extinct truncated retroposons drive low mRNA expression and developmental regulation in the protozoan Leishmania.

Ferreira G, Emond-Rheault J, Alves L, Leprohon P, Smith M, Papadopoulou B BMC Biol. 2024; 22(1):249.

PMID: 39468514 PMC: 11520807. DOI: 10.1186/s12915-024-02051-4.


Metabolic Pathways of Parasite: Source of Pertinent Drug Targets and Potent Drug Candidates.

Jain S, Sahu U, Kumar A, Khare P Pharmaceutics. 2022; 14(8).

PMID: 36015216 PMC: 9416627. DOI: 10.3390/pharmaceutics14081590.


A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against Infection.

Lage D, Vale D, Linhares F, Freitas C, Machado A, Cardoso J Vaccines (Basel). 2022; 10(7).

PMID: 35891310 PMC: 9317424. DOI: 10.3390/vaccines10071146.


Pathogen-Derived Nucleases: An Effective Weapon for Escaping Extracellular Traps.

Liao C, Mao F, Qian M, Wang X Front Immunol. 2022; 13:899890.

PMID: 35865526 PMC: 9294136. DOI: 10.3389/fimmu.2022.899890.

References
1.
Palatnik-de-Sousa C, Barbosa A, Oliveira S, Nico D, Bernardo R, Santos W . FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine. Expert Rev Vaccines. 2008; 7(6):833-51. DOI: 10.1586/14760584.7.6.833. View

2.
Afonso M, Mestre A, Silva G, Almeida A, Cunha R, Meyer-Fernandes J . Extracellular Nucleotide Metabolism Promotes Neutrophils Extracellular Traps Escape. Front Cell Infect Microbiol. 2021; 11:678568. PMC: 8313894. DOI: 10.3389/fcimb.2021.678568. View

3.
Smooker P, Rainczuk A, Kennedy N, Spithill T . DNA vaccines and their application against parasites--promise, limitations and potential solutions. Biotechnol Annu Rev. 2004; 10:189-236. DOI: 10.1016/S1387-2656(04)10007-0. View

4.
Pace D . Leishmaniasis. J Infect. 2014; 69 Suppl 1:S10-8. DOI: 10.1016/j.jinf.2014.07.016. View

5.
Farajnia S, Mahboudi F, Ajdari S, Reiner N, Kariminia A, Alimohammadian M . Mononuclear cells from patients recovered from cutaneous leishmaniasis respond to Leishmania major amastigote class I nuclease with a predominant Th1-like response. Clin Exp Immunol. 2005; 139(3):498-505. PMC: 1809324. DOI: 10.1111/j.1365-2249.2004.02702.x. View